Atlas Trials

Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

Clinical trial NCT01159327 · TERMINATED

Trial details

NCT number
NCT01159327
Sponsor
National Cancer Center, Korea
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2010-12-01
Primary completion
2013-04-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.